News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Alfredo Addeo: The Phase 3 DeLLphi-304 trial met its primary endpoint
hug.ch
Apr 14, 2025, 03:45

Alfredo Addeo: The Phase 3 DeLLphi-304 trial met its primary endpoint

Alfredo Addeo, Head of Oncology Department at Geneva University Hospitals, shared a post on X:

“Breaking: The Phase 3 DeLLphi-304 trial met its primary endpoint: Imdelltra (tarlatamab-dlle) significantly improved overall survival vs SOC in SCLC patients post-platinum. A major step forward for this hard-to-treat disease. Look forward to seeing the data.”

Alfredo Addeo: The Phase 3 DeLLphi-304 trial met its primary endpoint

Alfredo Addeo cancer OncoDaily Oncology
Special Coverage
Career
May 29, 2025, 16:54
Paulo Bergerot: Proud and Grateful for 2024 Reviewer Recognition from JCO Global Oncology
Blog
May 29, 2025, 16:50
Shubh Goel: Discover AstraZeneca’s Vision for Cancer Care at ASCO 2025
Blog
May 29, 2025, 16:37
Children’s Cancer Institute Shares Jack’s Journey Through Brain Cancer and Clinical Trial Success
Science
May 29, 2025, 16:36
Beliz Bahar Karaoğlan: Unveiling the Role of Human Papillomavirus in Urogenital Carcinogenesis
Blog
May 29, 2025, 16:26
Porscha Johnson: Two More Days Before Our Live Interactive Molecular Tumor Board at ASCO 2025
Blog
May 29, 2025, 16:16
From Targeted Therapies to Early Detection, Connect With SCRI at ASCO25 - Sarah Cannon Research Institute
Blog
May 29, 2025, 15:41
Meet The Translational and Therapeutic Research in Pancreatic Cancer Team at Cancer Research Centre of Marseille - AFRCP
Career
May 29, 2025, 15:32
Join University of Arizona Cancer Center at ASCO 2025 to Explore Oncology Job Opportunities
Blog
May 29, 2025, 15:10
FORwards Special Interest Group Webinar on Fear of Cancer Recurrence Featuring Expert Christine Maheu
Blog
May 29, 2025, 14:19
Anna Cabanes on ATOM Coalition's Milestone in Global Cancer Access Program at the Recent Workshop in Zambia
Insight
May 29, 2025, 14:15
New Biomarker May Guide Best Use of KRAS Inhibitors in Lung Cancer
Opinion
May 29, 2025, 13:47
Robin Zon and Andy Guinigundo Highlighted the Importance of Team Attendance at ASCO 2025